Results 241 to 250 of about 144,068 (308)

Oral misoprostol (PGE1) vs vaginal dinoprostone (PGE2) for labor induction: individual participant data meta‐analysis of randomized controlled trials

open access: yesUltrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objective To compare the effectiveness and safety of oral misoprostol vs vaginal dinoprostone for the induction of labor (IOL) using an individual participant data (IPD) meta‐analysis. Methods We used a Cochrane review and searched Ovid MEDLINE, Ovid Embase, Ovid Emcare, CINAHL Plus, Scopus and ClinicalTrials.gov to identify randomized ...
S. Y. Tan   +13 more
wiley   +1 more source

Early Postpartum Glucose Tolerance Reclassification by Gestational Diabetes Subtype.

open access: yesJAMA Netw Open
Van JAD   +9 more
europepmc   +1 more source

Prenatal detection and outcome of major heart defects in a country with universal screening

open access: yesUltrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objective To evaluate the Danish prenatal screening program for major fetal congenital heart defects (mCHD), focusing on incidence, detection rates (DRs), pregnancy outcomes and postnatal mortality. Methods This was a 5‐year nationwide cohort study conducted from January 2018 to December 2022 in Denmark.
C. Vedel   +15 more
wiley   +1 more source

Risk of pre‐eclampsia according to gestational age across three decades: population‐based study

open access: yesUltrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objectives To determine the risk of pre‐eclampsia in ongoing pregnancies according to gestational age. We also studied whether the gestational‐age‐specific risks of developing pre‐eclampsia have changed over recent decades. Methods This was a population‐based study using data from the Medical Birth Registry of Norway.
C. Haavaldsen, O. Thomas, A. Eskild
wiley   +1 more source

Predicting gestational diabetes before conception for personalized interpregnancy weight management. [PDF]

open access: yesSci Rep
Tano S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy